Lymphatic Delivery of -labeled Dextran Acetate Particles Including Cyclosporine A |
Kim, Jin
(Department of Advanced Chemicals Graduate School, Chonnam National University)
Chung, Kyong-Hwan (Center for Functional Nano Fine Chemicals, Chonnam National University) Lee, Chang-Moon (Department of Nuclear Medicine and Research Institute of Clinical Medicine, Chonbuk National University School of Medicine) Seo, Young-Soon (Department of Nuclear Medicine, Chonnam National University Medical School) Song, Ho-Chun (Department of Nuclear Medicine, Chonnam National University Medical School) Lee, Ki-Young (Center for Functional Nano Fine Chemicals, Chonnam National University) |
1 | Albertini, J. J., G. H. Lyman, C. Cox, T. Yeatman, L. Balducci, and N. Ku. 1996. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 11: 1818-1822 |
2 | Bhatnagar, A., A. K. Singh, D. Lahoti, T. Singh, and C. M. Khanna. 1996. Technetium-99m dextran: A promising new proteinlosing enteropathy imaging agent. Eur. J. Nucl. Med. 23: 575-578 DOI ScienceOn |
3 | Boinpally, R. R., S. L. Zhou, G. Devraj, P. K. Anne, S. Poondru, and D. R. Jasti. 2004. Iontophoresis of lecithin vesicles of cyclosporine A. Int. J. Pharm. 274: 185-190 DOI |
4 | Dansereau, R. N. and B. R. Line. 2000. Clinical production of pharmaceutical grade dextran 70 for lymphoscintigraphy. Clin. Nucl. Med. 25: 179-181 DOI ScienceOn |
5 | Drug Topics.com. http://www.drug-topics.com and search past issues |
6 | Holm R., C. J. H. Porter, G. A. Edwards, A. Mullertz, H. G. Kristensen, and W. N. Charman. 2003. Examination of oral absorption and lymphatic transport of halofantrine in a triplecannulated canine model after administration in selfmicroemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur. J. Pharm Sci. 20: 91-97 DOI ScienceOn |
7 | Kapoor, S., S. K. Ratan, R. Kashyap, S. K. Mittal, K. Rajeshwari, and H. Rawat. 2002. Detecting protein losing enteropathy by dextran scintigraphy: A novel experience. Indian J. Pediatr. 69: 761-764 DOI ScienceOn |
8 | Kim, C. K., S. A. Ryu, K. M. Park, S. J. Lim, and S. J. Hwang. 1997. Preparation and physicochemical characterization of phase inverted water/oil microemulsion containing CyA. Int. J. Pharm. 147: 131-134 DOI ScienceOn |
9 | Matsunaga, K., K. Hara, T. Imamura, T. Fujioka, J. Takata, and Y. Karube. 2005. Technetium labeling of dextran loading cysteamine as a ligand. Nucl. Med. Biol. 32: 279-285 DOI ScienceOn |
10 | Miyake, K., H. Arima, T. Irie, F. Hiraayama, and K. Uekama. 1998. Enhanced adsorption of CyA by complexation with dimethyl-beta-cyclodextrin in bile duct cannulated and noncannulated rats. Biol. Pharm. Sci. 22: 66-72 |
11 | Motozato, Y., H. Ihara, T. Tomoda, and C. Hirayama. 1986. Preparation and gel permeation chromatographic properties of pulluan sphere. J. Chromatogr. 335: 434-437 |
12 | Murdan, S., T. Andrysek, and D. Son. 2005. Novel gels and their dispersions-oral drug delivery and systems for cyclosporine. Int. J. Pharm. 300: 113-124 DOI |
13 | Park, K., W. S. E. Shalaby, and H. Park. 1993. Biodegradable Hydrogels for Drug Delivery. Technomic Publishing Inc., Lancaster |
14 | Xavier, N. L., B. B. Amaral, C. T. Cerski, S. C. Fuchs, B. L. Spiro, and O. L. Oliveira. 2001. Sentinel lymph node identification and sampling in women with early breast cancer using labeled dextran 500 and patent blue V dye. Nucl. Med. Commun. 22: 1109-1117 DOI |
15 | Lee, C.-M., Y.-J. Heo, H.-C. Song, H.-S. Bom, H.-C. Lee, H.-J. Jeong, and K.-Y. Lee. 2007. Radioevaluation of PAMs, CMs, and PS-Lip as an oral carrier for vaccine delivery into intestinal Peyer's patches. Drug Develop. Res. 67: 1-6 |
16 | McEvoy, G. K. (ed.). 1990. AHFS (American Hospital Formulary Services) Drug Information, pp. 2570-2576. American Society of Health-System Pharmacists, Bethesda, MD |
17 | Wang, X.-Q., J.-D. Dai, Z. Chen, T. Zhang, G.-M. Xia, T. Nagai, and Q. Zhang. 2004. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. J. Control. Release 97: 421-429 DOI |
18 | Odeberg, J. M., P. Kaufmann, K. G. Kroon, and P. Hoglund. 2003. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability applied to cyclosporine. Eur. J. Pharm. Sci. 20: 375-382 DOI |
19 | Bhatnagar, A., D. Lahoti, A. K. Singh, L. R. Shankar, B. Sharma, and T. Singh. 1995. Scintigraphic diagnosis of protein losing enteropathy using dextran. Clin. Nucl. Med. 20: 1070-1073 DOI |
20 | Caitriona, M. 2002. Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 15: 405-415 DOI ScienceOn |
21 | Marquez, M., J.-E. Westlin, S. Nilson, and A. R. Holmberg. 1996. antibody conjugates. Labeling procedures. Acta Oncol. 35: 489-492 DOI ScienceOn |
22 | Chacon, M., J. Molpeceres, L. Berges, M. Guzman, and M. R. Aberturas. 1999. Stability and freeze-drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriers. Eur. J. Pharma. Sci. 8: 99-107 DOI ScienceOn |
23 | Gao, Z. G., H. G. Choi, H. J. Shin, K. M. Park, S. J. Lim, K. J. Hwang, and C. K. Kim. 1998. Physicochemical characterization and evauation of a microemulsion system for oral delivery of CyA. Int. J. Pharm. 161: 75-86 DOI ScienceOn |
24 | Kao, C.-H., H.-T. Lin, S.-L. Yu, S.-J. Wang, and J.-L. Lan. 1995. Effects of corticosteroid inhalation therapy on the depositopn pattern of Tc-99m human serum albumin radioaerosols in asthma. Lung 173: 291-296 |
25 | Piato, J. R., A. C. Barros, K. M. Pincerato, A. P. Sampaio, and J. A. Pinotti. 2003. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur. J. Surg. Oncol. 29: 118-120 DOI ScienceOn |
26 | Vigario, A., M. T. Sapienza, A. P. Sampaio, J. R. Piato, N. Barros, and A. Barros. 2003. Primary chemotherapy effect in sentinel node detection in breast cancer. Clin. Nucl. Med. 28: 553-557 DOI ScienceOn |
27 | William, N. C. and J. H. P. Christopher. 1996. Lipophilic prodrugs designed for intestinal lymphatic transport. Adv. Drug Deliv. Rev. 19: 149-169 DOI ScienceOn |
28 | Tejani, A. 1998. Neoral: The microemulsion formulation. Pediatr. Transplant. 2: 85-86 |
29 | Bhatnagar, A., A. K. Singh, T. Singh, and L. R. Shankar. 1995. : A potential inflammation-seeking radiopharmaceutical. Nucl. Med. Commun. 16: 1058-1062 DOI ScienceOn |
30 | Neubauer, S., I. Mena, R. Iglesis, R. Schwartz, J. C. Acevedo, and A. Leon. 2001. Sentinel lymph node mapping in melanoma with technetium-99m dextran. Cancer Biother. Radiopharm. 16: 265-267 DOI ScienceOn |
31 | Kumar, V. and G. S. Banker. 1996. Target-oriented drug delivery systems, pp. 662-663. In G. S. Banker and C. T. Rhodes (eds.), Modern Pharmaceutics. Marcel Dekker, New York |
32 | Henze, E., H. R. Schelbert, J. D. Collins, A. Najafi, J. R. Bario, and L. R. Bennett. 1982. Lymphoscintigraphy with 99mTc labelled dextran. J. Nucl. Med. 23: 923-929 |
33 | Wingardh, K. and S.-E. Strand. 1989. Evaluation in vitro and in vivo of two labeling techniques of different for lymphoscintigraphy. Eur. J. Nucl. Med. 15: 146-151 |
34 | Holmberg, A., M. Marquez, J.-E. Westlin, and S. Nilson. 1995. Labeling of polypeptides with technetium-99m using a dextran spacer. Cancer Res. 55: 5710-5713 |
35 | Dass, R. S., A. K. Singh, and U. P. S. Chauhan. 1993. Development of a dextran kit for labelling with and its evaluation for lymphoscintigraphy. Nucl. Med. Biol. 20: 701-706 DOI ScienceOn |
36 | Edreira, M. M., L. L. Colombo, J. H. Perez, E. O. Sajaroff, and S. G. de Castiglia. 2001. In vivo evaluation of three different radiopharmaceuticals for sentinel lymph node identification. Nucl. Med. Commun. 22: 499-504 DOI ScienceOn |
37 | Guo, J., O. Ping, and Y. Chen. 2001. Pharmacokinetic behavior of cyclosporine A in rabbits by oral administration of lectin vesicle and Sandimmun Neoral. Int. J. Pharmaceut. 216: 17-21 DOI |
38 | Henze, E., G. G. Robinson, D. E. Kuhl, and H. R. Schelbert. 1982. dextran: A new blood-pool labeling agent for radionuclide angiocardiography. J. Nucl. Med. 23: 348-353 |
39 | Drewe, J., C. Beglinger, and T. Kissel. 1992. The absorption site of cyclosporine in the human gastrointestinal tract. Br. J. Clin. Pharmacol. 33: 39-43 DOI ScienceOn |
40 | Urata, T., K. Arimori, and H. Nakano. 1999. Modification of release rates of cyclosporine A from poly(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres. J. Control. Release 58: 133-141 DOI ScienceOn |
41 | Wang, X.-Q., J. Huang, J.-D. Dai, T. Zhang, W.-L. Lu, H. Zhang, X. Zhang, J.-C. Wang, and Q. Zhang. 2006. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid. In. J. Pharm. 322: 146-153 |
42 | Bhatnagar, A., A. K. Singh, T. Singh, R. S. Sethi, and N. L. Soni. 1998. Inflammation imaging using dextran. Clin. Nucl. Med. 23: 123-124 DOI ScienceOn |
43 | Dansereau, R. N. and B. R. Line. 1994. Preparation of dextran 70 injection labeled with technetium 99m for use as a cardiac blood-pool imaging agent. Am. J. Hosp. Pharm. 15: 2797-2800 |
44 | Ercan, M. T., M. Schneidereit, R. Senekowitsch, and H. Kriegel. 1985. Evaluation of as a lymphoscintigraphic agent in rabbits. Eur. J. Nucl. Med. 11: 80-84 |
45 | Jeong J. M., M. K. Hong, Y. J. Kim, J. Lee, J. H. Kang, D. S. Lee, J.-K. Chung, and M. C. Lee. 2004. Development of 99mTc-neomannosyl human serum albumin as a novel receptor binding agent for sentinel lymph node imaging. Nucl. Med. Commun. 25: 1211-1217 DOI ScienceOn |